Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients.

PURPOSE To evaluate the long-term results of embolotherapy of pulmonary arteriovenous malformations (PAVMs) in a large group of patients. MATERIALS AND METHODS Between July 1988 and August 2001, 134 consecutive patients underwent embolotherapy of PAVMs with feeding arteries larger than 3 mm or that had previously caused bleeding or systemic complications. The mean follow-up was 62.2 months. The primary endpoints of the study were the efficacy of embolotherapy, decrease in right-to-left shunt, and increase in partial arterial oxygen pressure (PaO(2)); the secondary endpoint was the prevalence of complications. Standard follow-up consisted of yearly history, chest radiography, and arterial blood gas measurement. RESULTS Follow-up was available in 112 patients. Initially, 296 PAVMs were embolized in these patients. Nineteen patients (17%) underwent a second procedure and four patients underwent a third procedure because of recanalization of originally occluded feeding arteries (25 PAVMs, 8%) or interval enlargement of untreated PAVMs (53 PAVMs). In total, 349 PAVMs were embolized in 157 sessions. The mean diameter of occluded vessels was 4.7 mm. The long-term outcomes of embolotherapy were successful in 83% of patients overall and in 96% of patients in whom all angiographically visible PAVMs were embolized. Recanalization occurred in 12 of 16 patients who underwent repeat treatment because of enlargement of nonembolized PAVMs. Postprocedural pleurisy occurred after 14 of 157 sessions (9%). Periprocedural complications occurred in 12 sessions (8%) and included migration of an embolic device, transient ischemic attack (TIA), angina pectoris, and early cerebral infarction after embolization. Three patients experienced TIA and two patients experienced a cerebral abscess during follow-up after embolotherapy. CONCLUSIONS Embolotherapy of PAVMs is efficacious and durable in the majority of patients. Patients should remain under regular review because recanalization of PAVMs or enlargement of untreated PAVMs can occur years after treatment.

[1]  J. Lammers,et al.  Quantification of right-to-left shunt with (99m)Tc-labelled albumin macroaggregates and 100% oxygen in patients with hereditary haemorrhagic telangiectasia. , 2002, Clinical science.

[2]  T. Overtoom,et al.  Early cerebral infarction after embolotherapy of a pulmonary arteriovenous malformation. , 2001, Journal of vascular and interventional radiology : JVIR.

[3]  Tengyu Ma,et al.  Pulmonary arteriovenous malformations , 2000, Neurology.

[4]  M. Letarte,et al.  Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia. , 2000, Trends in cardiovascular medicine.

[5]  A. Guttmacher,et al.  Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). , 2000, American journal of medical genetics.

[6]  Y. Lui,et al.  Diffuse pulmonary arteriovenous malformations: characteristics and prognosis. , 2000, Chest.

[7]  C. Shovlin,et al.  Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms , 1999, Thorax.

[8]  R. White,et al.  Embolotherapy of pulmonary arteriovenous malformations with detachable balloons: long-term durability and efficacy. , 1999, Journal of vascular and interventional radiology : JVIR.

[9]  J. Gossage,et al.  Pulmonary arteriovenous malformations. A state of the art review. , 1998, American journal of respiratory and critical care medicine.

[10]  M. Nakajo,et al.  Recanalization after coil embolotherapy of pulmonary arteriovenous malformations: study of long-term outcome and mechanism for recanalization. , 1998, AJR. American journal of roentgenology.

[11]  J. Hughes.  Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia , 1998 .

[12]  T. Egglin,et al.  Embolotherapy of large pulmonary arteriovenous malformations: long-term results. , 1997, The Annals of thoracic surgery.

[13]  J. T. ten Berg,et al.  Unusual complications after embolization of a pulmonary arteriovenous malformation. , 1996, Chest.

[14]  D. Allison,et al.  Pulmonary arteriovenous malformations: results of treatment with coil embolization in 53 patients. , 1995, AJR. American journal of roentgenology.

[15]  J. Lammers,et al.  Embolisation of pulmonary arteriovenous malformations: results and follow up in 32 patients. , 1995, Thorax.

[16]  R. White,et al.  Pulmonary arteriovenous malformations: diagnosis with three-dimensional helical CT--a breakthrough without contrast media. , 1994, Radiology.

[17]  T. Egglin,et al.  Clinical results of transvenous systemic embolotherapy with a neuroradiologic detachable balloon. , 1994, Radiology.

[18]  J. Wain,et al.  Pulmonary arteriovenous malformations: therapeutic options. , 1993, The Annals of thoracic surgery.

[19]  J. Remy,et al.  Pulmonary arteriovenous malformations: evaluation with CT of the chest before and after treatment. , 1992, Radiology.

[20]  J. Remy,et al.  Transcatheter occlusion of pulmonary arterial circulation and collateral supply: failures, incidents, and complications. , 1991, Radiology.

[21]  S. Mitchell,et al.  Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. , 1988, Radiology.

[22]  W. Porstmann.  Therapeutic Embolization of Arteriovenous Pulmonary Fistulas by Catheter Technique , 1977 .

[23]  O. Eklöf,et al.  Current Concepts in Pediatric Radiology , 1977 .